Stay updated on PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link/section has been removed, previously shown as Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T10:18:30.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.3.1 was removed.
    Difference
    0.0%
    Check dated 2025-12-01T17:40:53.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The Publications section now clarifies that the publications pertain to study results, and the page footer Revision line has been updated from Revision: v3.2.0 to Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:48:54.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Removal of the government funding notice that warned the page may not be up to date. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:59:31.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The page shows a reorganization of sections and minor formatting changes with updated headers, while core trial content such as eligibility criteria, endpoints, and treatment details remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:44.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Updated page with a government-funding status notice and an OS/operational update for the NIH Clinical Center, plus a version bump to v3.2.0; the previous v3.1.0 tag was removed.
    Difference
    1%
    Check dated 2025-10-05T10:31:06.000Z thumbnail image

Stay in the know with updates to PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.